The future is brimming with possibilities for AI in healthcare, but eliminating bias is imperative, so where should pharma start?

AI holds buckets of potential for medical affairs teams, but it must be adopted considerately and correctly to meet their needs.

Pharma’s approach to customer experience could be improved with humanisation of digital touchpoints.

Novo Nordisk’s new obesity drug could be set to transform obesity care, but there’s much more that pharma can do to help.

GSK’s Judy Stewart discusses her ambition to work in pharmaceuticals and make a difference to public health, the vast GSK vaccine pipeline, leadership and the importance of work-life balance.

What are the generation differences in how HCPs want to talk to pharma? Three generations of doctors share their thoughts.

AstraZeneca’s Mina Makar talks about solving unmet needs and how to champion the patient perspective.

Many top pharma companies have cut their Twitter ad spend after the Eli Lilly scandal, but should they take a risk and return?